Dechra Pharmaceuticals Plc (DPH.L) Share Price & News
Bid
--
-
Ask
- High-
- OPEN-
- VOL-
- MKT CAP-M
- LOW-
- CLOSE-
- SHARES IN ISSUE113.89M
Dechra Pharmaceuticals Plc Company Profile
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.